Welltower (WELL) Stock Looks Above Fair Value Despite A 208% Run

Welltower, Inc.

Welltower, Inc.

WELL

0.00

Welltower stock has delivered very strong returns over the past five years, yet current checks suggest investors are paying a premium, with the intrinsic value estimate sitting close to the market price while earnings based multiples screen as expensive.

  • Welltower has returned about 208% over 5 years, which puts extra focus on whether the current share price already reflects much of the long term upside.
  • Expectations for steady cash flow from its healthcare focused real estate portfolio may support the current valuation, while any pressure on property level income or funding costs could weigh on what investors are willing to pay.
  • Across a broader set of valuation checks, Welltower does not screen as a bargain, with 0 out of 6 tests pointing to the shares as cheap.

The key question is whether Welltower's current price, which is near the Discounted Cash Flow intrinsic value estimate but above what traditional multiples suggest, still offers an appealing entry point for long term investors.

Spot other income focused real estate stocks that may offer a clearer margin of safety by scanning our hand picked 12 dividend fortresses.

Does Welltower Look Fairly Valued on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what future cash flows from Welltower are worth in today’s dollars. For Welltower, the model uses adjusted funds from operations and last twelve month free cash flow of about $1.82b, with projections that assume growing cash generation rather than a shrinking business.

On these inputs, the DCF model points to an intrinsic value of about $229 per share, which sits slightly below the current market price. That gap implies the stock screens as roughly 4.7% overvalued on this cash flow view. The margin between price and value is not wide, so small changes in free cash flow expectations or the discount rate could shift the conclusion.

Overall, the DCF work suggests Welltower stock currently looks about fairly valued, with only a small premium to the intrinsic value estimate.

Welltower is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

WELL Discounted Cash Flow as at Aug 2026
WELL Discounted Cash Flow as at Aug 2026

Has Welltower Run Too Far on Earnings?

P/E is a useful cross check for Welltower because investors often anchor on earnings-based metrics for listed REITs alongside cash flow.

Welltower trades on a P/E ratio of about 111.4x, which is far above the Health Care REITs industry average of 16.7x and also above the peer group average of 91.6x. A fair P/E multiple based on Welltower's profile is estimated at about 40.0x. This is materially lower than where the stock currently trades, so the market is attaching a sizeable premium to each dollar of current earnings.

The gap between the present P/E and this fair ratio suggests investors are already paying up for Welltower relative to sector norms and to what the model implies is justified by its characteristics.

On the P/E multiple alone, Welltower stock looks overvalued compared with both its industry and the modelled fair ratio.

NYSE:WELL P/E Ratio as at Aug 2026
NYSE:WELL P/E Ratio as at Aug 2026

The Welltower Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where this valuation puzzle for Welltower leaves off and focus on the specific assumptions about future growth, margins and earnings that would need to hold for the stock to be worth materially more or less than today's price on the Community page.

Each Welltower narrative sets out a clear and testable view of fair value that is tied to the business so you can watch how that thesis holds up as new information arrives over time.

Community views on Welltower split between a bullish growth and dividend story and a more cautious take on what the current valuation already prices in.

Bull case: 18% undervalued

"Welltower’s substantial exposure to the surging 75+ age group and its dominant position in senior housing positions the company for sustained multi-year occupancy and revenue growth..."

Bear case: roughly fairly valued

"Rising macroeconomic uncertainties and high investment levels heighten risks to occupancy, revenue growth, and net margins amidst inflation and interest rate pressures..."

Do you think there's more to the story for Welltower? Head over to our Community to see what others are saying!

The Bottom Line

For Welltower, the Discounted Cash Flow (DCF) work points to an intrinsic value close to the current share price, while the earnings based multiples suggest the stock is overvalued relative to peers and its own fair ratio estimate. That mix leaves little clear valuation cushion and shifts the focus to execution and funding discipline rather than a simple mispricing. The crux for investors now is whether Welltower can sustain cash generation and justify a premium multiple on earnings, or whether sentiment cools and the valuation moves closer to sector norms.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.